DAVID BATES to Cardiovascular Diseases
This is a "connection" page, showing publications DAVID BATES has written about Cardiovascular Diseases.
Connection Strength
0.242
-
Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough. J Gen Intern Med. 2004 Jun; 19(6):684-91.
Score: 0.097
-
Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19. J Allergy Clin Immunol. 2020 10; 146(4):808-812.
Score: 0.074
-
Pharmacosurveillance without borders: electronic health records in different countries can be used to address important methodological issues in estimating the risk of adverse events. J Clin Epidemiol. 2016 09; 77:101-111.
Score: 0.055
-
Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies. Pharmacoepidemiol Drug Saf. 2018 07; 27(7):781-788.
Score: 0.016